New insights into the treatment of meningoencephalomyelitis of unknown origin since 2009: a review of 671 cases

N Jeffery, N Granger - Frontiers in Veterinary Science, 2023 - frontiersin.org
“Meningoencephalomyelitis of unknown origin”(MUO)—a collective term for a group of
clinically-indistinguishable (but pathologically distinct) autoimmune diseases of the CNS …

Clinical presentation, diagnostic findings, and long-term survival time in 182 dogs with meningoencephalitis of unknown origin from Central Europe that were …

TK Paušová, A Tomek, P Šrenk, S Belašková - Topics in Companion …, 2021 - Elsevier
Canine non-infectious inflammatory meningoencephalomyelitis is termed
meningoencephalomyelitis of unknown origin (MUO) and may affect dogs of every breed at …

Clinical presentation, diagnostic findings, prognostic factors, treatment and outcome in dogs with meningoencephalomyelitis of unknown origin: a review

I Cornelis, L Van Ham, I Gielen, S De Decker… - The Veterinary …, 2019 - Elsevier
Meningoencephalomyelitis of unknown origin (MUO) encompasses a group of idiopathic,
most likely immune mediated, inflammatory central nervous system diseases that cause …

Efficacy of glucocorticoid monotherapy for treatment of canine meningoencephalomyelitis of unknown etiology: a prospective study in 16 dogs

M Mercier, HL Barnes Heller - Veterinary Medicine and Science, 2015 - Wiley Online Library
Canine non‐infectious, inflammatory meningoencephalomyelitis is termed
meningoencephalomyelitis of unknown etiology (MUE) and may affect dogs of any age …

Evaluation of treatment with a combination of mycophenolate mofetil and prednisolone in dogs with meningoencephalomyelitis of unknown etiology: a retrospective …

JH Song, DH Yu, HC Lee, TS Hwang, YJ Kim… - BMC veterinary …, 2020 - Springer
Background Combination therapy with glucocorticoids and adjunctive immunomodulating
drugs has been generally accepted as a standard treatment regimen for …

Comparison of two regimens for the treatment of meningoencephalomyelitis of unknown etiology

PM Smith, CE Stalin, D Shaw… - Journal of veterinary …, 2009 - Wiley Online Library
Background: The optimal treatment for meningoencephalomyelitis of unknown etiology
(MUE) remains unknown, despite the widespread use of a variety of immunosuppressive …

Treatment with cytarabine at initiation of therapy with cyclosporine and glucocorticoids for dogs with meningoencephalomyelitis of unknown origin is not associated …

R Barber, L Downey Koos - Frontiers in Veterinary Science, 2022 - frontiersin.org
Meningoencephalomyelitis of unknown origin (MUO) is a common disorder of dogs that
results in significant morbidity and mortality. The ideal treatment regimen is not known but a …

Perspectives on pharmacologic strategies in the management of meningoencephalomyelitis of unknown origin in dogs

MJ Beasley, A Shores - Frontiers in Veterinary Science, 2023 - frontiersin.org
There are many non-infectious inflammatory diseases, assumed to be immune-mediated in
origin, recognized to affect the nervous system in canine patients. Concentrating on …

Metagenomic investigation of idiopathic meningoencephalomyelitis in dogs

LL Hoon‐Hanks, S McGrath, KL Tyler… - Journal of veterinary …, 2018 - Wiley Online Library
Background Meningoencephalomyelitis of unknown origin (MUO) is a common and life‐
threatening neuroinflammatory disease in dogs. Features of the disease are suggestive of …

Survival time and relapse in dogs with meningoencephalomyelitis of unknown origin treated with prednisolone and ciclosporin: a retrospective study

SL Brady, AP Woodward… - Australian veterinary …, 2020 - Wiley Online Library
Objective To analyse outcome in dogs with a presumptive diagnosis of
meningoencephalomyelitis of unknown origin (MUO) treated with prednisolone and …